Inobaseru

504A.TTSE GROWTHPharmaceutical
Filed as Innovacell Inc. (2026-03–2026-08)
Financials · Standalone
Fiscal year ended2025-122024-122023-122022-122021-12
Operating income−¥702m−¥636m———
Ordinary income−¥753m−¥772m−¥516m−¥514m−¥292m
Total assets¥7.5bn¥4.1bn¥2.5bn¥2.1bn¥1.2bn
Net assets / equity¥7.4bn¥3.6bn¥2.1bn¥1.8bn¥139m
EPS (basic)¥-23.5¥-28.89¥-19.45¥-20.64¥-44.74

From EDINET filings. Select any figure to open the report it came from. r = changed in a later filing (the report page shows the original). — = not reported in the filings structured so far.

Reports · 1
PeriodFormFiledFigures
2026-01-01 → 2026-06-30Half-year2026-08-0660 figures · EDINET